GlassScriptPhysician profile
Terence Williams
NPI 1740807585
$8,609.42
in general payments reported to CMS, 2019-2025
35 companies · $1,870 in 2025
The $1,870 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $973 · 2022: $1,834 · 2023: $2,386 · 2024: $1,546 · 2025: $1,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,676 · Education: $94.99 · Consulting Fee: $25.30 · Travel and Lodging: $6.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,675.82 |
| Education | $94.99 |
| Consulting Fee | $25.30 |
| Travel and Lodging | $6.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,598.83 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,986.14 | 2021-2025 | Fasenra, Tezspire, Breztri |
| Amgen INC. | $783.64 | 2021-2025 | Tezspire |
| Genzyme Corporation | $692.36 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $391.84 | 2021-2024 | Dupixent |
| Mylan Specialty L.P. | $236.39 | 2021-2024 | Yupelri |
| Insmed, INC. | $200.69 | 2023-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $179.09 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Takeda Pharmaceuticals U.S.A., INC. | $143.30 | 2021-2025 | Glassia, Hyqvia |
| Medtronic, INC. | $142.88 | 2022 | |
| Aytu Biopharma, INC. | $138.50 | 2022-2024 | Karbinal |
| Baxter Healthcare | $134.43 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Sanofi-Aventis U.S. LLC | $94.99 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $93.44 | 2023-2024 | Opsumit, Uptravi |
| Genentech USA, INC. | $83.86 | 2022-2024 | Xolair |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.78 | 2021-2025 | Spiriva Respimat, Jascayd, Stiolto Respimat |
| Philips North America LLC | $64.37 | 2025 | Vest Therapy Und |
| Hikma Pharmaceuticals USA | $52.02 | 2023 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $51.23 | 2024-2025 | |
| Inogen, INC. | $48.17 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Viatris Specialty LLC | $48.02 | 2025 | Yupelri |
| Advanced Respiratory, INC | $45.13 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $40.22 | 2021-2022 | |
| Lilly USA, LLC | $39.05 | 2025 | Zepbound |
| Electromed, INC. | $34.89 | 2025 | Smartvest |
| Paratek Pharmaceuticals, INC. | $29.15 | 2022-2023 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $25.58 | 2023 | Acthar |
| Adma Biomanufacturing LLC | $25.30 | 2025 | |
| Phadia US INC. | $24.85 | 2022 | |
| Verona Pharma, INC. | $22.22 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $18.95 | 2025 | Lumryz |
| Inspire Medical Systems, INC. | $17.87 | 2025 | Inspire |
| Nabriva Therapeutics, Plc | $16.62 | 2022 | |
| Ani Pharmaceuticals, INC. | $15.62 | 2025 | Purified Cortrophin Gel |
| Intuitive Surgical, INC. | $6.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terence Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.